ATOS · Atossa Therapeutics, Inc. · Webcasts, Transcripts & Audio
$1.65
-0.10 (-5.71%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2023 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$15.92M
Shares
9.98M
Volume · Nov 20
48.93K
Avg daily vol (3M)
67.59K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Atossa Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Atossa Therapeutics, Inc. (ATOS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Investor Update
Investor event
2026-05-19
Atossa Therapeutics, Inc. (ATOS) May 19, 2026 Investor Update Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q4
2025-03-25
Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q2
2023-08-14
Atossa Therapeutics, Inc. (ATOS) Q2 2023 Earnings Call Transcript
Diluted EPS
$-1.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–3 of 3 webcasts
Key facts
CIK
1488039
CUSIP
04962H704
13F (30d)
61 filings
35 filers
Visit website
Investor relations